Dl-dapoxetine hcl

Basic Information

View in Editor

CAS Number

1071929-03-7

Molecular Formula

C21H24ClNO

Molecular Weight

341.88 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Ethers

Agricultural Chemicals Pesticides Herbicides

Basic Physical Properties

SMILES

View in Editor

CN(C(c1ccccc1)CCOc1cccc2c1cccc2)C.Cl

InChI

InChI=1S/C21H23NO.ClH/c1-22(2)20(18-10-4-3-5-11-18)15-16-23-21-14-8-12-17-9-6-7-13-19(17)21;/h3-14,20H,15-16H2,1-2H3;1H

InChIKey

IHWDIQRWYNMKFM-UHFFFAOYSA-N

LogP

5.3334000000000055

Topological Polar Surface Area

12.47 Å²

Hydrogen Bond Donor/Acceptor

0 / 2

Complexity

337

Synonyms & References

English

DL-Dapoxteine HCL
DL-Dapoxetine Hydrochloride
(R)-Dapoxetine Hydrochloride
(1S)-N,N-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine;hydrochloride
Dapoxetina

MDL Number

MFCD20922882

FAQ

What regulatory guidelines apply to Dl-dapoxetine HCl (CAS: 1071929-03-7)?

Dl-dapoxetine HCl (CAS: 1071929-03-7) is subject to various regulatory guidelines. In the European Union, it falls under REACH regulations, requiring identification, assessment, and authorization for substances. In the United States, FDA guidelines for drug substances and EPA regulations for environmental protection and safe handling apply. GHS classification is also relevant for its physical and health hazards.

Are there alternatives to Dl-dapoxetine HCl (CAS: 1071929-03-7) in synthesis?

In synthesis, there are several alternatives to Dl-dapoxetine HCl (CAS: 1071929-03-7). Common analogs include DL-Dapoxetine, and alternative reagents such as 4-(4-aminobenzoyl)piperazine and N-(3,4-dihydroxyphenyl)acetamide can be used as substitutes. These alternatives offer similar pharmacological properties but may require different synthesis conditions.

What is the market or research trend for Dl-dapoxetine HCl (CAS: 1071929-03-7)?

The market for Dl-dapoxetine HCl (CAS: 1071929-03-7) remains stable, with increasing research focus on its antidepressant and anti-anxiety effects. Recent trends include studies on its efficacy and safety profiles, with a growing emphasis on its potential as a treatment for depression and anxiety disorders. Market trends suggest a continued demand for this compound in pharmaceutical research and development.

How should waste containing Dl-dapoxetine HCl (CAS: 1071929-03-7) be handled?

Waste containing Dl-dapoxetine HCl (CAS: 1071929-03-7) should be collected in appropriate, labeled containers and stored in a secure, well-ventilated area. Incineration is a common method for disposal, ensuring complete destruction of the compound. Alternatively, professional waste disposal services can handle the waste safely, adhering to environmental protection measures and regulatory requirements. All waste management should comply with local and international guidelines to prevent environmental contamination.